Cargando…

Effects of adenosine and regadenoson on hemodynamics measured using cardiovascular magnetic resonance imaging

BACKGROUND: Adenosine or regadenoson vasodilator stress cardiovascular magnetic resonance (CMR) is an effective non-invasive strategy for evaluating symptomatic coronary artery disease. Vasodilator injection typically precedes ventricular functional sequences to efficiently reduce overall scanning t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Dustin M., Minor, Matthew R., Aden, James K., Lisanti, Christopher J., Steel, Kevin E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5713097/ https://www.ncbi.nlm.nih.gov/pubmed/29202847 http://dx.doi.org/10.1186/s12968-017-0409-8

Ejemplares similares

Cardiovascular effects and tolerance of adenosine versus regadenoson during cardiac MRI perfusion testing
por: Minor, Matthew, et al.
Publicado: (2015)

Regadenoson cardiovascular magnetic resonance myocardial perfusion imaging predicts need for future revascularization
por: Freed, Benjamin H, et al.
Publicado: (2012)

Prognostic value of normal regadenoson stress perfusion cardiovascular magnetic resonance
por: Freed, Benjamin H, et al.
Publicado: (2013)

Considerations when measuring myocardial perfusion reserve by cardiovascular magnetic resonance using regadenoson
por: Bhave, Nicole M, et al.
Publicado: (2012)

Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance
por: Vasu, Sujethra, et al.
Publicado: (2013)

Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping
por: van Dijk, R., et al.
Publicado: (2017)

Safety and prognostic value of regadenoson stress cardiovascular magnetic resonance imaging in heart transplant recipients
por: Kazmirczak, Felipe, et al.
Publicado: (2019)

Hemodynamic and Respiratory Effects of Regadenoson During Radiologic Imaging in Infants and Children
por: Schloss, Brian, et al.
Publicado: (2021)

Safety, feasibility, and hemodynamic response of regadenoson for stress perfusion CMR
por: Muñiz-Sáenz-Diez, Javier, et al.
Publicado: (2023)

The effect of obesity on regadenoson-induced myocardial hyperemia: a quantitative magnetic resonance imaging study
por: DiBella, Edward V. R., et al.
Publicado: (2011)

Editorial: Regadenoson: An adenosine A(2A) receptor agonist for pharmacological myocardial perfusion imaging
por: Matsuo, Shinro
Publicado: (2014)

Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls
por: Burrage, Matthew K., et al.
Publicado: (2021)

Epicardial adipose tissue measured by magnetic resonance imaging predicts abnormal adenosine stress cardiovascular magnetic resonance imaging and future adverse cardiovascular events
por: Lamanna, Jason J, et al.
Publicado: (2013)

Feasibility and preliminary diagnostic results of pixel-wise quantification of regadenoson first pass cardiac magnetic resonance perfusion imaging
por: Ta, Allison D, et al.
Publicado: (2014)

Quantitative myocardial perfusion response to adenosine and regadenoson in patients with suspected coronary artery disease
por: Kero, Tanja, et al.
Publicado: (2021)

Regadenoson as a pharmacologic stressor in cardiac magnetic resonance imaging in congenital and acquired pediatric heart disease: initial experience
por: Noel, Cory V, et al.
Publicado: (2015)

Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance imaging
por: Karamitsos, Theodoros D, et al.
Publicado: (2011)

Seizure: An Adverse Effect of Regadenoson in Myocardial Perfusion Imaging
por: Radwan, Sohab S., et al.
Publicado: (2019)

Safety and tolerability of regadenoson CMR
por: Nguyen, Kim-Lien, et al.
Publicado: (2014)

Comparative efficacy and safety of adenosine and regadenoson for assessment of fractional flow reserve: A systematic review and meta-analysis
por: Gill, Gauravpal Singh, et al.
Publicado: (2022)

Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy
por: Husain, Nazia, et al.
Publicado: (2021)

Serious complications associated with regadenoson administration for myocardial perfusion imaging
por: Kitt, Therese, et al.
Publicado: (2014)

Severe Shivering as an Adverse Effect of Regadenoson Myocardial Perfusion Imaging
por: Ahmad, Tanjeev, et al.
Publicado: (2021)

Effects of caffeine on the detection of ischemia in patients undergoing adenosine stress cardiovascular magnetic resonance imaging
por: Greulich, Simon, et al.
Publicado: (2017)

Regadenoson in the detection of coronary artery disease
por: Buhr, Christiane, et al.
Publicado: (2008)

The Diameter of Retinal Arterioles Is Unaffected by Intravascular Administration of the Adenosine A(2A) Receptor Agonist Regadenoson in Normal Persons
por: Dons-Jensen, Anna, et al.
Publicado: (2019)

Adenosine vs. regadenoson for stress induction in dynamic CT perfusion scan of the myocardium: A single‑center retrospective comparison
por: Gibarti, Claudia, et al.
Publicado: (2023)

Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance
por: Karamitsos, Theodoros D, et al.
Publicado: (2010)

Time resolved measure of coronary sinus flow following regadenoson administration
por: Booker, O Julian, et al.
Publicado: (2011)

Regadenoson in Europe: first-year experience of regadenoson stress combined with submaximal exercise in patients undergoing myocardial perfusion scintigraphy
por: Brinkert, M., et al.
Publicado: (2013)

Inferior Myocardial Infarction Secondary to Coronary Artery Vasospasm Following Regadenoson Stress Imaging
por: Fogelson, Benjamin, et al.
Publicado: (2022)

Hemodynamic matrix factorization for functional magnetic resonance imaging
por: Hütel, Michael, et al.
Publicado: (2021)

Stress perfusion cardiac MRI with regadenoson and gadofoveset trisodium
por: Allen, Bradley D, et al.
Publicado: (2015)

Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease
por: Chih, Sharon, et al.
Publicado: (2010)

Comparison of Regadenoson and Dipyridamole Safety Profiles During Stress Myocardial Perfusion Imaging
por: Roczniak, Jan, et al.
Publicado: (2023)

The reliability and feasibility of non-contrast adenosine stress cardiovascular magnetic resonance T1 mapping in patients on haemodialysis
por: Poli, Federica E, et al.
Publicado: (2020)

Cardiovascular magnetic resonance in pregnancy: Insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study
por: Ducas, Robin A, et al.
Publicado: (2014)

The EXERRT trial: “EXErcise to Regadenoson in Recovery Trial”: A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol
por: Thomas, Gregory S., et al.
Publicado: (2017)

Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain
por: Lerakis, Stamatios, et al.
Publicado: (2009)

Adenosine cardiac magnetic resonance: follow-up of patients with very high cardiovascular risk
por: Esteban-Fernández, Alberto, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_po97tmk9ie4r758j1u9suq7eo4